Earlier this week, legal newswire Law360 published an expert commentary article entitled “Cosmetics Under Fire: Tips to Avoid FDA Scrutiny” (subscription required). The article warns attorneys for the cosmetic industry that the FDA and plaintiffs’ attorneys are both targeting the industry for its fraudulent marketing practices.
Lori McGroder, the author of the article, cites as a prime example Morelli Alters Ratner’s class action lawsuit against L’Oreal and Lancôme, which alleges that the companies used deceptive and misleading advertising/marketing to sell “anti-aging” skin cream. As Ms. McGroder notes, our class action has been followed by two others making similar claims. Read the FDA’s warning letter against Lancôme USA here.
The article also mentions proposed class actions that have been filed against Avon for similar deceptive practices. Read the FDA’s warning letter against Avon here.